Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Catabasis Pharmaceuticals Inc. (CATB)

0.8022 -0.036 (-4.26%)

09-21 11:31

Open:

0.83

Pre. Close:

0.8379

High:

0.839

Low:

0.7944

Volume:

360,272

Market Cap:

57M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.86 - 0.863

0.863 - 0.866

Low:

0.812 - 0.815

0.815 - 0.819

Close:

0.824 - 0.829

0.829 - 0.834

Technical analysis  (as of: 2018-09-21 10:56:27 AM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months:     One year: 1.17

Support:

Support1: 0.70    Support2: 0.61

Resistance:

Resistance1: 0.86    Resistance2:

Pivot:

0.77

Moving Averages:

MA(5): 0.80     MA(20): 0.76

MA(100): 1.03     MA(250): 1.50

MACD:

MACD(12,26): 0.02     Signal(12,26,9): 0.01

%K %D:

%K(14,3): 80.45     %D(3): 73.29

RSI:

RSI(14): 56.31

52-Week:

High: 3.78  Low: 0.61  Change(%): -56.1

Average Vol(K):

3-Month: 97082  10-Days 108269

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
CATB has closed below upper band by 27.3%. Bollinger Bands are 48.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to CATB's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-09-19T08:00:00-04:00
Catabasis Pharmaceuticals to Present New Edasalonexent Clinical Results and Phase 3 Trial Design in Duchenne Muscular Dystrophy at the World Muscle Society Congress

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

71.04

Shares Float (M)

70.53

% Held by Insiders

% Held by Institutions

32.40

Shares Short (K)

158

Shares Short Prior Month (K)

Stock Financials

EPS

-1.040

EPS Est. Current Year

-1.390

EPS Est. Next Year

-1.100

EPS Est. Next Quarter

-0.330

Forward EPS

-1.190

Book Value (p.s.)

1.270

PEG Ratio

Profit Margin

Operating Margin

-5157.80

Return on Assets (ttm)

-64.7

Return on Equity (ttm)

-78.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.096

Qtrly Earnings Growth

Operating Cash Flow (M)

-25.47

Levered Free Cash Flow (M)

-14.70

Valuation

P/E

-0.77

P/E Growth Ratio

-0.03

P/BV

0.63

P/S

2850835456.00

P/CF

-2.24

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.